I work as part of the MS research team carrying out commercial and academic studies. I am also involved in the biology of MS and novel imaging techniques.
et al., [(11)C]PBR28 or [(18)F]PBR111 detect white matter inflammatory heterogeneity in multiple sclerosis., Journal of Nuclear Medicine, ISSN:1535-5667
et al., 2018, Remote Monitoring in the Home Validates Clinical Gait Measures for Multiple Sclerosis, Frontiers in Neurology, Vol:9, ISSN:1664-2295
et al., 2018, Mononuclear cell transcriptome changes associated with dimethyl fumarate in MS, Neurology - Neuroimmunology Neuroinflammation, Vol:5, Pages:e470-e470
et al., 2018, The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis, Neurology, Vol:90, ISSN:0028-3878, Pages:E2107-E2118
et al., 2018, Baseline characteristics of the CASTING Study population: a Phase IIIB Trial evaluating Ocrelizumab in patients with relapsing-remitting Multiple Sclerosis and suboptimal response to disease-modifying therapies, 4th Congress of the European-Academy-of-Neurology (EAN), WILEY, Pages:190-190, ISSN:1351-5101